Most people survive a pulmonary embolism when it’s diagnosed and treated promptly. The critical window is the first few hours and days. Once you get through the acute phase, long-term survival depends on the severity of the clot, what caused it, and whether you experience complications or recurrence afterward. There’s no single answer to how long you can live, because a pulmonary embolism ranges from a minor event you fully recover from to a life-threatening emergency.
Surviving the First 30 Days
The immediate danger of a pulmonary embolism comes from the clot blocking blood flow to your lungs, which strains your heart. How much of that blood flow gets blocked determines severity. Most pulmonary embolisms are classified as low or intermediate risk, and the vast majority of those patients survive with anticoagulant treatment.
High-risk pulmonary embolisms, where the clot is large enough to cause dangerously low blood pressure or heart failure, are a different story. A meta-analysis in the Journal of the Society for Cardiovascular Angiography & Interventions found that 30-day mortality for high-risk patients averaged 30.2%. That means roughly 7 in 10 patients survived even in the most dangerous category. For low-risk patients, 30-day mortality drops to the low single digits.
Without any treatment, pulmonary embolism is far more lethal. Historical estimates put untreated mortality around 25 to 30% overall, including cases that would otherwise be considered lower risk. Anticoagulant therapy (blood thinners) reduces that dramatically, which is why fast diagnosis matters so much.
What Determines Long-Term Outlook
Once you survive the initial event, several factors shape your prognosis for years to come.
The most important distinction is whether your PE was “provoked” or “unprovoked.” A provoked PE has a clear, temporary trigger: surgery, a long flight, a broken leg, pregnancy, or a hospital stay. An unprovoked PE happens without an obvious cause. This matters because unprovoked PEs carry roughly double the recurrence risk compared to provoked ones. If your clot had a clear, reversible trigger that’s now resolved, your long-term outlook is significantly better.
Other factors that influence survival include your age, whether you have cancer (a major driver of blood clots), the degree of heart strain during the initial event, and whether you have underlying lung or heart disease. A younger person whose PE was triggered by oral contraceptives and a long flight has a very different trajectory than an older patient with metastatic cancer.
Risk of a Second Clot
Recurrence is the biggest ongoing threat to long-term survival after a pulmonary embolism. A second clot can be more dangerous than the first, and data from the American Society of Hematology shows that patients whose first event was a PE (rather than a leg clot alone) face higher fatality rates if a recurrence happens.
For unprovoked clots, a large study published in Circulation tracked recurrence over a decade. The annual recurrence rate was about 8.9% in the first year after stopping blood thinners. The cumulative probability of recurrence climbed to roughly 14% at 2 years, 25% at 5 years, and 32% at 10 years. That risk is highest in the first two years after stopping anticoagulant therapy, then gradually declines before settling into a steady rate of about 3% per year indefinitely.
For provoked clots, recurrence is substantially lower. The cumulative incidence is around 15% at 10 years, roughly half the unprovoked rate. This is why doctors often recommend that patients with unprovoked PE stay on blood thinners indefinitely, while those with a clear temporary trigger may stop after three to six months.
Long-Term Complications That Affect Quality of Life
Survival isn’t the whole picture. Up to half of PE survivors experience lasting functional impairment, a condition increasingly recognized as post-pulmonary embolism syndrome. In one trial that followed 100 patients for a year after their acute PE, 46.5% had reduced exercise capacity on formal testing, shorter walking distances, and lower quality-of-life scores. Symptoms include persistent shortness of breath with exertion, fatigue, and reduced stamina that doesn’t fully resolve even after the clot itself has been treated.
A smaller but significant subset of survivors, roughly 2.7%, develop a condition where old clot material scars into the lung’s blood vessels and permanently raises blood pressure in those vessels. This leads to progressive shortness of breath and heart strain that worsens over time if untreated. Early detection makes a major difference in outcomes, so lingering breathlessness months after a PE warrants follow-up testing rather than just waiting it out.
What Recovery Typically Looks Like
Most people start feeling noticeably better within a few weeks of starting treatment, but full recovery often takes longer than expected. Three to six months is a common timeline for returning to your previous activity level, and some people need closer to a year. The clot itself doesn’t dissolve overnight. Your body gradually breaks it down while blood thinners prevent new clots from forming.
During recovery, you’ll likely take anticoagulant medication daily. The duration depends on your risk profile. Three months is standard for a first provoked PE with a clear temporary cause. For unprovoked PE or recurrent clots, many patients stay on blood thinners for years or indefinitely. The tradeoff is straightforward: blood thinners reduce clot recurrence but carry a small ongoing risk of bleeding, and that bleeding risk stays constant over time while the risk of recurrence gradually decreases. Your doctor weighs those two risks against each other when deciding how long to continue treatment.
Gradual return to physical activity is encouraged and actually improves outcomes. Structured exercise programs after PE have shown benefits for both physical capacity and the anxiety that commonly follows a clot event. Many survivors describe the psychological impact, the fear of another clot, as one of the hardest parts of recovery.
The Bottom Line on Life Expectancy
For the majority of PE survivors, life expectancy is not dramatically shortened. If your PE was provoked by a temporary risk factor, you received prompt treatment, and you don’t have major underlying health conditions, your long-term prognosis is good. The key variables are avoiding recurrence (which blood thinners accomplish effectively), monitoring for complications like chronic pulmonary hypertension, and addressing the exercise limitations that affect up to half of survivors. People live decades after a pulmonary embolism. The ones who do best are those who stay on prescribed anticoagulation, stay physically active, and follow up on symptoms that don’t resolve.